Notice of clarification to drug manufacturers and sponsors - Risk Management Plans - Update (English, HTML)

View metadata and access the original English HTML file: Notice of clarification to drug manufacturers and sponsors - Risk Management Plans - Update.

Format

HTML

Access

file-only

Publisher-reported update

2024-04-04

This notice is being issued to clarify to drug manufacturers and sponsors that elements of Risk Management Plans (RMPs) required by Health Canada, such as controlled distribution programs, are not intended to restrict access to Canadian Reference Products (CRPs) for generic drug manufacturers for the purposes of conducting comparative testing.

Access original file